SEC Form 4 research
| Issuer | OCULAR THERAPEUTIX, INC |
|---|---|
| Tickers | OCUL |
| Reporting owners | 52 |
| Officers and directors | 18 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-08 | Anderman Todd | S | 11,984 | $7.29 | Not reported |
| 2026-10-06 | 2026-10-02 | Kaiser Peter | S | 9,990 | $7.05 | Not reported |
| 2026-10-06 | 2026-10-02 | Heier Jeffrey S. | S | 10,869 | $7.05 | Not reported |
| 2026-09-02 | 2026-08-31 | Notman Donald | S | 1,099 | $10.24 | Not reported |
| 2026-08-26 | 2026-08-24 | Kaiser Peter | S | 3,035 | $10.77 | Not reported |
| 2026-08-26 | 2026-08-24 | Nayak Sanjay | S | 1,897 | $10.78 | Not reported |
| 2026-08-26 | 2026-08-24 | Heier Jeffrey S. | S | 3,296 | $10.78 | Not reported |
| 2026-08-26 | 2026-08-24 | Dugel Pravin | S | 21,649 | $10.77 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.